HK2 knockdown inhibited the proliferation, migration, and invasion of DLBCL cells in vitro and restricted tumor growth in vivo, and these effects were associated with the suppression of the ERK1/2 signaling pathway. The gene discussed is MAPK3; the disease is diffuse large B-cell lymphoma.